Price T Rowe Associates Inc Oric Pharmaceuticals, Inc. Call Options Transaction History
Price T Rowe Associates Inc
- $869 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ORIC
# of Institutions
124Shares Held
66.6MCall Options Held
7.8KPut Options Held
700-
Nextech Invest Ag5.29MShares$44.1 Million8.84% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$40.3 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY4.39MShares$36.7 Million4.67% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA4.14MShares$34.6 Million2.29% of portfolio
-
Viking Global Investors LP4MShares$33.4 Million0.16% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $330M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...